ATE196653T1 - Expressionssystem - Google Patents

Expressionssystem

Info

Publication number
ATE196653T1
ATE196653T1 AT92901357T AT92901357T ATE196653T1 AT E196653 T1 ATE196653 T1 AT E196653T1 AT 92901357 T AT92901357 T AT 92901357T AT 92901357 T AT92901357 T AT 92901357T AT E196653 T1 ATE196653 T1 AT E196653T1
Authority
AT
Austria
Prior art keywords
expression systems
desired polypeptide
cdna
vector
expression system
Prior art date
Application number
AT92901357T
Other languages
English (en)
Inventor
Melvyn Hollis
Maurice Ronald Charles Needham
Clare Gooding
Franklin Geradus Grosveld
Michael Antoniou
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ATE196653T1 publication Critical patent/ATE196653T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Massaging Devices (AREA)
  • Cephalosporin Compounds (AREA)
AT92901357T 1990-12-21 1991-12-19 Expressionssystem ATE196653T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027917A GB9027917D0 (en) 1990-12-21 1990-12-21 Expression systems
PCT/GB1991/002274 WO1992011380A1 (en) 1990-12-21 1991-12-19 Expression systems

Publications (1)

Publication Number Publication Date
ATE196653T1 true ATE196653T1 (de) 2000-10-15

Family

ID=10687512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901357T ATE196653T1 (de) 1990-12-21 1991-12-19 Expressionssystem

Country Status (18)

Country Link
US (1) US5538885A (de)
EP (1) EP0516787B1 (de)
JP (1) JP3148237B2 (de)
KR (1) KR920703830A (de)
AT (1) ATE196653T1 (de)
AU (1) AU660636B2 (de)
CA (1) CA2058280A1 (de)
CS (1) CS267192A3 (de)
DE (1) DE69132429T2 (de)
FI (1) FI923758A0 (de)
GB (2) GB9027917D0 (de)
HU (1) HUT66062A (de)
IE (1) IE914497A1 (de)
IL (1) IL100413A0 (de)
NZ (1) NZ241045A (de)
PL (1) PL295798A1 (de)
WO (1) WO1992011380A1 (de)
ZA (1) ZA9110015B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627268A (en) * 1994-06-07 1997-05-06 Dnx Biotherapeutics Hemoglobin comprising globin fusion proteins
US5821351A (en) * 1994-06-10 1998-10-13 Dnx Biotherapeutics Production of hemoglobin having a delta-like globin
GB9505777D0 (en) * 1995-03-22 1995-05-10 Zeneca Ltd Process
JP2000516472A (ja) * 1996-08-16 2000-12-12 メディカル リサーチ カウンシル 組織特異的遺伝子発現を与える自己複製型エピソーム性発現ベクター
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US6284496B1 (en) 1997-10-03 2001-09-04 University Of South Florida DNA vector for determining the presence of out-of-reading-frame mutations
CA2334217C (en) * 1998-06-08 2007-04-17 Acgt Medico, Inc. Detection of dna, rna and proteins
GB9910664D0 (en) 1999-05-07 1999-07-07 Zeneca Ltd Cells and assay
US6645745B1 (en) * 2000-05-30 2003-11-11 Epidauros Biotechnologie Ag Identification of a new member of the cytochrome P450 3A (CYP3A) gene family: CYP3AX
US7033806B2 (en) * 2000-06-08 2006-04-25 The Regents Of The University Of California HY2 family of bilin reductases
US7326549B2 (en) * 2001-03-19 2008-02-05 Cargill, Incorporated Myo-inositol oxygenases
WO2002097137A1 (en) * 2001-05-29 2002-12-05 The Regents Of The University Of California Light controlled gene expression utilizing heterologous phytochromes
AU2003261103A1 (en) * 2002-07-02 2004-01-23 Uab Research Foundation Compounds promoting delivery of genes
US7795397B2 (en) * 2004-05-06 2010-09-14 The Regents Of The University Of California Red and near infrared flourescent phyotochrome
RU2716991C2 (ru) 2014-11-05 2020-03-17 Вояджер Терапьютикс, Инк. Полинуклеотиды aadc для лечения болезни паркинсона
WO2018044933A1 (en) 2016-08-30 2018-03-08 The Regents Of The University Of California Methods for biomedical targeting and delivery and devices and systems for practicing the same
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CA3070087A1 (en) 2017-07-17 2019-01-24 Voyager Therapeutics, Inc. Trajectory array guide system
KR20210019996A (ko) 2018-05-15 2021-02-23 보이저 테라퓨틱스, 인크. 파킨슨병의 치료를 위한 조성물 및 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663281A (en) * 1984-03-22 1987-05-05 Mass Institute Of Technology Enhanced production of proteinaceous materials in eucaryotic cells
CA1297435C (en) * 1986-09-12 1992-03-17 Stephen D. Gillies Messenger rna stabilization in animal cells
AU613316B2 (en) * 1986-09-12 1991-08-01 Genentech Inc. Improved recombinant expression
GB8718779D0 (en) * 1987-08-07 1987-09-16 Grosveld F G Dna sequence & expression vector
JP2779192B2 (ja) * 1987-09-17 1998-07-23 マサチユセツツ・インスチチユート・オブ・テクノロジー ヒト赤血球特異的転写エンハンサー
GB8904009D0 (en) * 1989-02-22 1989-04-05 Celltech Ltd Vector
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
AU6505690A (en) * 1989-09-26 1991-04-28 Richard R Behringer Erythroid-specific gene expression system
FI914947A0 (fi) * 1990-02-22 1991-10-21 Biogen Inc Foerbaettrad expression av polypeptider.

Also Published As

Publication number Publication date
GB9027917D0 (en) 1991-02-13
GB2251622B (en) 1995-05-03
AU660636B2 (en) 1995-07-06
JP3148237B2 (ja) 2001-03-19
IL100413A0 (en) 1992-09-06
KR920703830A (ko) 1992-12-18
DE69132429D1 (de) 2000-11-02
GB2251622A (en) 1992-07-15
CA2058280A1 (en) 1992-06-22
PL295798A1 (en) 1993-07-12
IE914497A1 (en) 1992-07-01
US5538885A (en) 1996-07-23
JPH05504261A (ja) 1993-07-08
GB9126984D0 (en) 1992-02-19
ZA9110015B (en) 1992-10-28
CS267192A3 (en) 1992-12-16
EP0516787A1 (de) 1992-12-09
FI923758A7 (fi) 1992-08-20
FI923758L (fi) 1992-08-20
DE69132429T2 (de) 2001-03-01
HUT66062A (en) 1994-09-28
HU9202458D0 (en) 1992-10-28
FI923758A0 (fi) 1992-08-20
WO1992011380A1 (en) 1992-07-09
AU9096891A (en) 1992-07-22
EP0516787B1 (de) 2000-09-27
NZ241045A (en) 1994-11-25

Similar Documents

Publication Publication Date Title
DE69132429D1 (de) Expressionssystem
DE69034179D1 (de) Expressionssysteme für ein amidierendes System
PT728214E (pt) Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
EP0260148A3 (de) Rekombinantes Expressionsverfahren, Vektor und tranformierte Zellen
ES8602138A1 (es) Metodo de controlar la expresion de un gen que codifica una proteinaheterologa deseada.
AU2795292A (en) Synthetic dna sequence having enhanced insecticidal activity in maize
WO1994003616A3 (fr) Vecteur de clonage et/ou de sequençage
IE822817L (en) Stabilization and selection of host cells containing¹recombinant dna
GB2147585B (en) Cdna clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity
GB8625435D0 (en) Human apolipoprotein ai
DE69634819D1 (de) Reguliertes autokrines wachstum von säugerzellen
AU3668389A (en) Exogenous gene expression vector containing chick beta-actin gene promoter
EP1040184A4 (de) Escherichia coli hochexpressionsvektor
ES8800353A1 (es) Procedimiento de clonacion de factor humano viii-r.
NO923271L (no) Ekspresjonssystemer
DK1071798T3 (da) Konstruktioner til reguleret ekspression af rekombinante gener i prokaryote celler
EP0160190A3 (de) Genetische Expression von Somatostatin als Hybridpolypeptid
ATE93893T1 (de) Expressionssysteme zur ueberproduktion gewuenschter proteine.
IT1262957B (it) Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties